GB201909194D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB201909194D0
GB201909194D0 GBGB1909194.1A GB201909194A GB201909194D0 GB 201909194 D0 GB201909194 D0 GB 201909194D0 GB 201909194 A GB201909194 A GB 201909194A GB 201909194 D0 GB201909194 D0 GB 201909194D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1909194.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB1909194.1A priority Critical patent/GB201909194D0/en
Publication of GB201909194D0 publication Critical patent/GB201909194D0/en
Priority to PCT/EP2020/067759 priority patent/WO2020260426A1/fr
Ceased legal-status Critical Current

Links

GBGB1909194.1A 2019-06-26 2019-06-26 Therapeutic agents Ceased GB201909194D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1909194.1A GB201909194D0 (en) 2019-06-26 2019-06-26 Therapeutic agents
PCT/EP2020/067759 WO2020260426A1 (fr) 2019-06-26 2020-06-24 Dérivés d'imidazole fusionnés utilisés en tant que modulateurs d'il-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1909194.1A GB201909194D0 (en) 2019-06-26 2019-06-26 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB201909194D0 true GB201909194D0 (en) 2019-08-07

Family

ID=67511757

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1909194.1A Ceased GB201909194D0 (en) 2019-06-26 2019-06-26 Therapeutic agents

Country Status (2)

Country Link
GB (1) GB201909194D0 (fr)
WO (1) WO2020260426A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127685A1 (fr) 2018-12-19 2020-06-25 Leo Pharma A/S Anilides d'acides aminés en tant que modulateurs à petites molécules d'il-17
WO2021170631A1 (fr) 2020-02-25 2021-09-02 UCB Biopharma SRL Dérivés de difluorocyclohexyle utilisés en tant que modulateurs d'il-17
WO2021170627A1 (fr) 2020-02-25 2021-09-02 UCB Biopharma SRL Dérivés de difluorocyclohexyle utilisés en tant que modulateurs d'il-17
CN115702024A (zh) 2020-04-07 2023-02-14 Ucb生物制药有限责任公司 用作il-17调节剂的二氟环己基衍生物
WO2021204800A1 (fr) 2020-04-07 2021-10-14 UCB Biopharma SRL Dérivés de difluorocyclohexyle utilisés en tant que modulateurs d'il-17
BR112022021962A2 (pt) 2020-04-30 2023-03-28 Janssen Pharmaceutica Nv Imidazopiridazinas como moduladores de il-17
BR112022025028A2 (pt) 2020-06-12 2023-01-31 Leo Pharma As Moduladores de molécula pequena de il-17
WO2021255174A1 (fr) 2020-06-18 2021-12-23 Leo Pharma A/S Modulateurs à petites molécules d'il-17
WO2021255086A1 (fr) 2020-06-18 2021-12-23 Leo Pharma A/S Modulateurs à petites molécules d'il-17
WO2021255085A1 (fr) 2020-06-18 2021-12-23 Leo Pharma A/S Modulateurs à petites molécules d'il-17
US20230399328A1 (en) 2020-11-09 2023-12-14 UCB Biopharma SRL Dicyclopropylmethyl derivatives as il-17 modulators
WO2022096411A1 (fr) 2020-11-09 2022-05-12 UCB Biopharma SRL Dérivés de dicyclopropylméthyle en tant que modulateurs d'il-17
JP2023552864A (ja) 2020-12-14 2023-12-19 ユーシービー バイオファルマ エスアールエル Ｉｌ－１７モジュレータとしてのイミダゾピリダジン誘導体
AR126255A1 (es) 2021-07-01 2023-10-04 UCB Biopharma SRL Derivados de imidazotriazina como moduladores de il-17
WO2023025783A1 (fr) 2021-08-23 2023-03-02 Leo Pharma A/S Modulateurs à petites molécules d'il-17
WO2023111181A1 (fr) 2021-12-16 2023-06-22 Leo Pharma A/S Modulateurs à petites molécules d'il-17
WO2023166172A1 (fr) 2022-03-04 2023-09-07 Leo Pharma A/S Modulateurs à petites molécules d'il-17

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
CA3069576A1 (fr) 2008-01-09 2009-07-16 The Schepens Eye Research Institute, Inc. Compositions therapeutiques utilisees pour le traitement des affections inflammatoires oculaires
US9284283B2 (en) 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17
CN104602690A (zh) * 2012-08-29 2015-05-06 默克专利股份有限公司 用于治疗骨关节炎的ddr2抑制剂
WO2014066726A2 (fr) 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Composés pour la modulation d'il-17
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
CA3088764A1 (fr) 2018-01-15 2019-07-18 UCB Biopharma SRL Derives d'imidazole fusionnes utilises en tant qu'inhibiteurs d'il-17

Also Published As

Publication number Publication date
WO2020260426A1 (fr) 2020-12-30

Similar Documents

Publication Publication Date Title
GB201909190D0 (en) Therapeutic agents
GB201909194D0 (en) Therapeutic agents
GB201909191D0 (en) Therapeutic agents
GB201820166D0 (en) Therapeutic agents
GB201820165D0 (en) Therapeutic agents
GB201902277D0 (en) Therapeutic agents
GB201805816D0 (en) Therapeutic agents
GB201900702D0 (en) Therapy
GB201906804D0 (en) Therapeutic agents
IL288237A (en) Combined treatment
GB201906864D0 (en) Combination therapy
GB201913759D0 (en) Therapeutic agents
GB201911865D0 (en) Therapeutic agents
GB201911712D0 (en) Therapeutic agents
GB201820164D0 (en) Therapeutic agents
GB201820168D0 (en) Therapeutic agents
GB201820170D0 (en) Therapeutic agents
GB201820172D0 (en) Therapeutic agents
GB201820162D0 (en) Therapeutic agents
GB201820160D0 (en) Therapeutic agents
GB201811753D0 (en) Therapeutic agents
GB201811467D0 (en) Therapeutic agents
GB201800639D0 (en) Therapeutic agents
IL289130A (en) Combined treatment
GB201919036D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)